Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ADC Therapeutics S.A. (ADCT)
USD1.26
+0.03 (+2.03%)
CH NYSE S&P 500
Healthcare Biotechnology
Address
Biopole 1066
Epalinges, CH
Epalinges, CH
CEO
Ameet Mallik
Website
adctherapeutics.com
IPO
2020-05-18
CIK 1771910 ISIN CH0499880968
Description
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Phase III trial assessing its combination with rituximab for second-line, transplant-ineligible patients with relapsed or refractory DLBCL; and a Phase I trial for relapsed or refractory non-Hodgkin lymphoma (NHL). The company's pipeline also includes camidanlumab tesirine, another ADC, which has completed Phase I development for relapsed or refractory NHL. It is additionally progressing through Phase II for relapsed or refractory Hodgkin lymphoma and Phase Ib for selected advanced solid tumors. Furthermore, ADC Therapeutics is advancing ADCT-602, currently in Phase Ia for acute lymphoblastic leukemia, alongside ADCT-601 and ADCT-901, both of which are in Phase Ia for various solid tumors. Its preclinical portfolio features ADCT-701 and ADCT-901, both aimed at solid tumors. The company maintains strategic collaboration and license agreements with entities such as Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. Founded in 2011, ADC Therapeutics S.A. has its headquarters located in Epalinges, Switzerland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 1999-07-30 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.26
+0.03 (+2.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.77
Float Shares
93.68M
Free Float %
73.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.57% | -10.08% | -6.95% | -13.43% | -14.07% | -1.42% | +159.70% | +48.72% | -83.96% | -88.26% | -88.26% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
1.26
Low
5.00
+298.4%
Consensus
7.50
+497.6%
Median
7.50
+497.6%
High
10.00
+696.8%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
7.50
+497.6%
|
| All Time | 7 |
10.57
+742.2%
|
Quality scores
Altman Z-Score
-7.33
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+14.9% ★ Q1'26: -9.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+30.9% ★ Q1'26: +41.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-225.7% Q1'26: -142.6% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-133.2% Q1'26: -121.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +387.9% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+30.8% Q1'26: +43.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-4.12× Q1'26: -4.19× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 1 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 1.29M (-100.0%)
|
33.92M
est: 33.01M (+2.8%)
|
209.91M
est: 187.67M (+11.8%)
|
69.56M
est: 66.75M (+4.2%)
|
70.84M
est: 72.66M (-2.5%)
|
81.36M
est: 80.57M (+1.0%)
|
81.39M
73.99M – 86.59M
+1.0% YoY
|
136.90M
118.00M – 149.37M
+68.2% YoY
|
282.29M
256.63M – 300.32M
+106.2% YoY
|
410.07M
372.79M – 436.27M
+45.3% YoY
|
462.42M
420.39M – 491.97M
+12.8% YoY
|
| EBITDA |
-218.23M
est: -646.9K (-33,636.0%)
|
-230.54M
est: -16.59M (-1,289.6%)
|
-107.70M
est: -94.33M (-14.2%)
|
-145.83M
est: -60.25M (-142.1%)
|
-102.65M
est: -65.59M (-56.5%)
|
-106.50M
est: -72.72M (-46.5%)
|
-73.46M
-78.15M – -66.78M
-1.0% YoY
|
-123.57M
-134.82M – -106.51M
-68.2% YoY
|
-254.80M
-271.07M – -231.64M
-106.2% YoY
|
-370.13M
-393.78M – -336.49M
-45.3% YoY
|
-417.39M
-444.06M – -379.45M
-12.8% YoY
|
| EBIT |
-219.05M
est: -649.8K (-33,610.3%)
|
-233.17M
est: -16.67M (-1,299.1%)
|
-110.09M
est: -94.75M (-16.2%)
|
-149.09M
est: -60.40M (-146.9%)
|
-105.93M
est: -65.75M (-61.1%)
|
-108.38M
est: -72.91M (-48.7%)
|
-73.65M
-78.35M – -66.95M
-1.0% YoY
|
-123.88M
-135.16M – -106.78M
-68.2% YoY
|
-255.44M
-271.76M – -232.22M
-106.2% YoY
|
-371.07M
-394.77M – -337.34M
-45.3% YoY
|
-418.44M
-445.17M – -380.41M
-12.8% YoY
|
| Net Income |
-246.29M
est: -342.78M (+28.1%)
|
-230.03M
est: -334.37M (+31.2%)
|
-157.13M
est: -202.24M (+22.3%)
|
-240.05M
est: -313.04M (+23.3%)
|
-157.85M
est: -207.76M (+24.0%)
|
-142.62M
est: -178.53M (+20.1%)
|
-108.01M
-110.46M – -105.55M
+39.5% YoY
|
-74.97M
-94.03M – -55.91M
+30.6% YoY
|
7.24M
6.50M – 7.98M
+109.7% YoY
|
78.78M
69.47M – 85.32M
+988.1% YoY
|
106.48M
93.90M – 115.33M
+35.2% YoY
|
| SGA |
77.23M
est: 2.17M (+3,456.9%)
|
136.24M
est: 55.69M (+144.6%)
|
143.49M
est: 316.62M (-54.7%)
|
105.89M
est: 98.14M (+7.9%)
|
85.91M
est: 106.84M (-19.6%)
|
-6.82M
est: 118.46M (-105.8%)
|
119.67M
108.79M – 127.31M
+1.0% YoY
|
201.29M
173.50M – 219.62M
+68.2% YoY
|
415.07M
377.34M – 441.58M
+106.2% YoY
|
602.95M
548.14M – 641.47M
+45.3% YoY
|
679.93M
618.13M – 723.37M
+12.8% YoY
|
| EPS |
-3.77
est: -3.53 (-6.9%)
|
-3.00
est: -3.44 (+12.8%)
|
-1.99
est: -2.07 (+3.9%)
|
-2.94
est: -2.51 (-17.2%)
|
-1.62
est: -1.69 (+4.1%)
|
-1.12
est: -1.41 (+20.3%)
|
-0.85
-0.87 – -0.83
+39.5% YoY
|
-0.62
-0.74 – -0.44
+27.3% YoY
|
0.06
0.05 – 0.06
+109.4% YoY
|
0.62
0.55 – 0.67
+969.0% YoY
|
0.84
0.74 – 0.91
+35.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-114.14M
OE per share TTM
-0.83
Owner's Yield
-21.28%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
18
Total invested
1.93M
Insider transactions (90d)
0
Beneficial owners (>5%)
30
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A.T. Holdings II Sarl | 22.19M | 28.90% | — | 22.19M | — | 10.00 | OO | Switzerland | 2020-10-13 | ↗ |
| 2 | Auven Therapeutics GP Ltd. | 22.19M | 28.90% | — | 22.19M | — | 10.00 | CO | British Virgin Islands | 2020-10-13 | ↗ |
| 3 | Auven Therapeutics General L.P. | 22.19M | 28.90% | — | 22.19M | — | 10.00 | PN | British Virgin Islands | 2020-10-13 | ↗ |
| 4 | Auven Therapeutics Holdings L.P. | 22.19M | 28.90% | — | 22.19M | — | 10.00 | PN | British Virgin Islands | 2020-10-13 | ↗ |
| 5 | C.T. Phinco Sarl | 22.19M | 28.90% | 22.19M | — | 22.19M | 10.00 | OO | Luxembourg | 2020-10-13 | ↗ |
| 6 | Peter B. Corr | 22.19M | 28.90% | — | 22.19M | — | 10.00 | IN | USA | 2020-10-13 | ↗ |
| 7 | Stephen Evans-Freke | 22.19M | 28.90% | — | 22.19M | — | 10.00 | IN | Ireland | 2020-10-13 | ↗ |
| 8 | Wild | 8.55M | 12.10% | 8.55M | — | 8.55M | — | IN | Switzerland | 2020-09-14 | ↗ |
| 9 | Abigail P. Johnson | 7.76M | 10.12% | — | — | 7.76M | — | IN | Delaware | 2021-04-12 | ↗ |
| 10 | FMR LLC | 7.67M | 10.00% | 1.31M | — | 7.67M | — | HC | Delaware | 2022-02-09 | ↗ |
| 11 | Jeremy C. Green | 7.45M | 9.70% | — | 7.45M | — | 7.45M | HC, IN | United Kingdom | 2022-02-14 | ↗ |
| 12 | Redmile Group, LLC | 7.45M | 9.70% | — | 7.45M | — | 7.45M | IA, OO | Delaware | 2022-02-14 | ↗ |
| 13 | AG | 7.45M | 10.50% | 7.45M | — | 7.45M | — | CO | Switzerland | 2020-09-14 | ↗ |
| 14 | HPWH TH AG | 7.45M | 10.50% | 7.45M | — | 7.45M | — | CO | Switzerland | 2020-09-14 | ↗ |
| 15 | ADC Products Switzerland Sarl | 4.77M | 6.20% | — | 4.77M | — | 10.00 | OO | Switzerland | 2020-10-13 | ↗ |
| 16 | Prosight Management, LP | 4.30M | 5.30% | — | 4.30M | — | 4.30M | IA | Delaware | 2023-04-17 | ↗ |
| 17 | Prosight Partners, LLC | 4.30M | 5.30% | — | 4.30M | — | 4.30M | OO | Delaware | 2023-04-17 | ↗ |
| 18 | W. Lawrence Hawkins | 4.30M | 5.30% | — | 4.30M | — | 4.30M | HC, IN | Delaware | 2023-04-17 | ↗ |
| 19 | BAM Partners Trust | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 20 | Brookfield Asset Management Ltd. | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 21 | Brookfield Asset Management ULC | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 22 | Brookfield Corporation | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 23 | Oaktree Capital Group Holdings GP, LLC | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 24 | Oaktree Capital Holdings, LLC | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 25 | Oaktree Fund Administration, LLC | 4.28M | 5.19% | — | 4.28M | — | 4.28M | OO | DE | 2024-05-03 | ↗ |
| 26 | AstraZeneca PLC | 4.01M | 5.23% | 4.01M | — | 4.01M | — | CO | United Kingdom | 2021-02-10 | ↗ |
| 27 | AstraZeneca UK Limited | 4.01M | 5.23% | 4.01M | — | 4.01M | — | CO | United Kingdom | 2021-02-10 | ↗ |
| 28 | Prosight Plus Fund, LP | 1.40M | 1.70% | — | 1.40M | — | 1.40M | PN | Delaware | 2023-04-17 | ↗ |
| 29 | Prosight Fund, LP | 596.1K | 0.70% | — | 596.1K | — | — | PN | Delaware | 2023-04-17 | ↗ |
| 30 | Thomas Pfisterer | 497.0K | 0.70% | 108.8K | 388.2K | 108.8K | 388.2K | CO | Switzerland | 2020-09-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
18
-98 vs prev Q
New positions
2
Closed positions
98
Increased
10
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | REDMILE GROUP, LLC | 15.67M +— (+0.0%) | 55.30M -7.4M (-11.8%) | 11.48% -2.292 pp | 4.07% -2.024 pp | USD21.02 -83.2% | 23 qtrs — |
| 2 | TCG CROSSOVER MANAGEMENT, LLC | 11.39M +10.0M (+719.3%) | 40.21M +34.6M (+623.1%) | 8.35% +7.126 pp | 1.33% +1.057 pp | USD3.59 -1.7% | 2 qtrs — |
| 3 | PROSIGHT MANAGEMENT, LP | 8.48M +1.0M (+13.5%) | 29.93M +35.8K (+0.1%) | 6.21% -0.357 pp | 6.18% -0.787 pp | USD2.78 +27.0% | 14 qtrs — |
| 4 | ORBIMED ADVISORS LLC | 5.82M -84.5K (-1.4%) | 20.55M -3.1M (-13.0%) | 4.27% -0.926 pp | 0.42% -0.136 pp | USD3.25 +8.6% | 7 qtrs — |
| 5 | NANTAHALA CAPITAL MANAGEMENT, LLC | 5.48M +3.2M (+141.6%) | 19.33M +10.3M (+113.2%) | 4.01% +2.020 pp | 0.64% +0.324 pp | USD3.18 +11.0% | 3 qtrs — |
| 6 | BLACKROCK, INC. | 5.43M +915.6K (+20.3%) | 19.16M +1.1M (+6.2%) | 3.98% +0.011 pp | 0.00% +0.000 pp | USD3.10 +13.9% | 6 qtrs — |
| 7 | POINT72 ASSET MANAGEMENT, L.P. | 5.01M -3.1M (-38.4%) | 17.70M -14.8M (-45.6%) | 3.68% -3.478 pp | 0.02% -0.035 pp | USD2.74 +28.8% | 3 qtrs — |
| 8 | MORGAN STANLEY | 3.77M +100.7K (+2.7%) | 13.31M -1.4M (-9.3%) | 2.76% -0.463 pp | 0.00% 0.000 pp | USD4.06 -13.1% | 23 qtrs — |
| 9 | EVENTIDE ASSET MANAGEMENT, LLC | 3.36M +3.4M (+100.0%) | 11.88M +11.9M (+100.0%) | 2.47% +2.466 pp | 0.19% +0.186 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 10 | GOLDMAN SACHS GROUP INC | 1.64M +46.4K (+2.9%) | 5.79M -585.5K (-9.2%) | 1.20% -0.199 pp | 0.00% 0.000 pp | USD3.23 +9.3% | 14 qtrs — |
| 11 | STATE STREET CORP | 1.41M +111.4K (+8.6%) | 4.97M -215.9K (-4.2%) | 1.03% -0.108 pp | 0.00% +0.000 pp | USD3.49 +1.1% | 7 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 1.30M -62.7K (-4.6%) | 4.58M -861.2K (-15.8%) | 0.95% -0.245 pp | 0.00% +0.000 pp | USD2.86 +23.4% | 23 qtrs — |
| 13 | VANGUARD GROUP INC | 1.13M +535.6K (+90.2%) | 3.99M +1.6M (+67.8%) | 0.83% +0.306 pp | 0.00% +0.000 pp | USD3.42 +3.2% | 7 qtrs — |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 996.5K +133.6K (+15.5%) | 3.52M +66.0K (+1.9%) | 0.73% -0.028 pp | 0.00% +0.000 pp | USD3.57 -1.1% | 7 qtrs — |
| 15 | PLATINUM INVESTMENT MANAGEMENT LTD | 990.8K -165.9K (-14.3%) | 3.50M -1.1M (-24.4%) | 0.73% -0.291 pp | 0.81% +0.509 pp | USD3.03 +16.5% | 7 qtrs — |
| 16 | BLUE OWL CAPITAL HOLDINGS LP | 733.6K +— (+0.0%) | 2.93M +— (+0.0%) | 0.54% -0.107 pp | 0.22% -0.691 pp | USD4.82 -26.8% | 14 qtrs — |
| 17 | BNP PARIBAS ARBITRAGE, SNC | 830.9K +142.4K (+20.7%) | 2.93M +179.2K (+6.5%) | 0.61% +0.004 pp | 0.00% 0.000 pp | USD2.47 +42.9% | 5 qtrs — |
| 18 | VANTAGE CONSULTING GROUP INC | 683.0K +— (+0.0%) | 2.41M -321.0K (-11.8%) | 0.50% -0.100 pp | 12.23% -12.135 pp | USD32.01 -89.0% | 21 qtrs — |
| 19 | PANAGORA ASSET MANAGEMENT INC | 594.3K +50.0K (+9.2%) | 2.10M -79.3K (-3.6%) | 0.44% -0.043 pp | 0.01% -0.001 pp | USD3.24 +9.0% | 4 qtrs — |
| 20 | ACADIAN ASSET MANAGEMENT LLC | 529.0K +301.5K (+132.5%) | 1.86M +954.0K (+105.3%) | 0.39% +0.188 pp | 0.00% +0.002 pp | USD3.73 -5.4% | 2 qtrs — |
| 21 | STEMPOINT CAPITAL LP | 502.6K +219.3K (+77.4%) | 1.77M +640.9K (+56.6%) | 0.37% +0.119 pp | 0.30% +0.077 pp | USD3.05 +15.7% | 3 qtrs — |
| 22 | JPMORGAN CHASE & CO | 471.7K +141.1K (+42.7%) | 1.67M +342.7K (+25.9%) | 0.35% +0.055 pp | 0.00% +0.000 pp | USD3.80 -7.1% | 7 qtrs — |
| 23 | VOLEON CAPITAL MANAGEMENT LP | 464.2K +393.8K (+560.2%) | 1.64M +1.4M (+482.6%) | 0.34% +0.278 pp | 0.04% +0.028 pp | USD3.60 -1.9% | 2 qtrs — |
| 24 | NORTHERN TRUST CORP | 437.6K +20.0K (+4.8%) | 1.54M -125.7K (-7.5%) | 0.32% -0.046 pp | 0.00% +0.000 pp | USD3.12 +13.1% | 7 qtrs — |
| 25 | SCHRODER INVESTMENT MANAGEMENT GROUP | 418.8K +418.8K (+100.0%) | 1.47M +1.5M (+100.0%) | 0.31% +0.307 pp | 0.00% +0.001 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 26 | MILLENNIUM MANAGEMENT LLC | 328.4K -373.2K (-53.2%) | 1.16M -1.6M (-58.7%) | 0.24% -0.376 pp | 0.00% -0.001 pp | USD3.25 +8.6% | 17 qtrs — |
| 27 | WELLS FARGO & COMPANY/MN | 320.0K +250.5K (+360.5%) | 1.13M +851.8K (+306.4%) | 0.23% +0.174 pp | 0.00% +0.000 pp | USD3.34 +5.7% | 7 qtrs — |
| 28 | CITADEL ADVISORS LLC | 298.2K -522.5K (-63.7%) | 1.05M -2.2M (-67.9%) | 0.22% -0.503 pp | 0.00% 0.000 pp | USD3.95 -10.6% | 3 qtrs — |
| 29 | D. E. SHAW & CO., INC. | 263.1K +263.1K (+100.0%) | 928.6K +928.6K (+100.0%) | 0.19% +0.193 pp | 0.00% +0.001 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 30 | UBS GROUP AG | 215.2K -47.0K (-17.9%) | 759.7K -289.3K (-27.6%) | 0.16% -0.073 pp | 0.00% +0.000 pp | USD2.10 +68.1% | 8 qtrs — |
| 31 | WELLINGTON MANAGEMENT GROUP LLP | 212.9K -37.2K (-14.9%) | 751.6K -248.7K (-24.9%) | 0.16% -0.064 pp | 0.00% +0.000 pp | USD4.00 -11.8% | 2 qtrs — |
| 32 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 212.7K +30.7K (+16.8%) | 750.7K +22.7K (+3.1%) | 0.16% -0.004 pp | 0.00% +0.000 pp | USD3.61 -2.2% | 7 qtrs — |
| 33 | AQR CAPITAL MANAGEMENT LLC | 206.6K +61.3K (+42.2%) | 729.2K +148.2K (+25.5%) | 0.15% +0.024 pp | 0.00% +0.000 pp | USD2.26 +56.2% | 6 qtrs — |
| 34 | JANE STREET GROUP, LLC | 199.8K -288.1K (-59.1%) | 705.2K -1.2M (-63.9%) | 0.15% -0.283 pp | 0.00% 0.000 pp | USD4.00 -11.8% | 2 qtrs — |
| 35 | SQUAREPOINT OPS LLC | 173.9K -1.1K (-0.6%) | 613.8K -86.0K (-12.3%) | 0.13% -0.026 pp | 0.00% +0.000 pp | USD3.82 -7.6% | 6 qtrs — |
| 36 | BANK OF NEW YORK MELLON CORP | 173.0K +14.3K (+9.0%) | 610.6K -24.1K (-3.8%) | 0.13% -0.013 pp | 0.00% +0.000 pp | USD3.58 -1.4% | 7 qtrs — |
| 37 | JUMP FINANCIAL, LLC | 162.3K +150.7K (+1,299.8%) | 572.7K +526.4K (+1,135.3%) | 0.12% +0.109 pp | 0.01% +0.007 pp | USD3.56 -0.8% | 2 qtrs — |
| 38 | BARCLAYS PLC | 161.4K +33.6K (+26.3%) | 569.7K +167.3K (+41.6%) | 0.12% +0.006 pp | 0.00% +0.000 pp | USD3.12 +13.1% | 7 qtrs — |
| 39 | FMR LLC | 133.8K +370.0 (+0.3%) | 472.3K -61.4K (-11.5%) | 0.10% -0.019 pp | 0.00% +0.000 pp | USD2.42 +45.9% | 6 qtrs — |
| 40 | TWO SIGMA ADVISERS, LP | 120.6K +120.6K (+100.0%) | 425.6K +425.6K (+100.0%) | 0.09% +0.088 pp | 0.00% +0.001 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 41 | TWO SIGMA INVESTMENTS, LP | 119.5K +74.0K (+162.8%) | 421.7K +239.9K (+131.9%) | 0.09% +0.048 pp | 0.00% +0.000 pp | USD3.71 -4.9% | 8 qtrs — |
| 42 | NUVEEN, LLC | 118.9K -52.3K (-30.6%) | 419.8K -265.2K (-38.7%) | 0.09% -0.063 pp | 0.00% 0.000 pp | USD2.20 +60.5% | 4 qtrs — |
| 43 | STATE OF WISCONSIN INVESTMENT BOARD | 113.4K +113.4K (+100.0%) | 400.2K +400.2K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.001 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 44 | CREATIVE PLANNING | 113.2K +6.6K (+6.2%) | 399.8K -26.8K (-6.3%) | 0.08% -0.011 pp | 0.00% +0.000 pp | USD3.55 -0.6% | 5 qtrs — |
| 45 | SANIBEL CAPTIVA TRUST COMPANY, INC. | 113.0K +— (+0.0%) | 398.9K -53.1K (-11.8%) | 0.08% -0.017 pp | 0.01% -0.002 pp | USD4.37 -19.2% | 8 qtrs — |
| 46 | KINGSWOOD WEALTH ADVISORS, LLC | 105.0K +105.0K (+100.0%) | 370.7K +370.7K (+100.0%) | 0.08% +0.077 pp | 0.02% +0.018 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 47 | BRYN MAWR TRUST CO | 100.0K +— (+0.0%) | 353.0K -47.0K (-11.8%) | 0.07% -0.015 pp | 0.01% -0.001 pp | USD3.15 +12.1% | 6 qtrs — |
| 48 | CANTOR FITZGERALD, L. P. | 100.0K +100.0K (+100.0%) | 353.0K +353.0K (+100.0%) | 0.07% +0.073 pp | 0.01% +0.005 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 49 | RHUMBLINE ADVISERS | 90.7K -9.8K (-9.7%) | 320.1K -81.8K (-20.4%) | 0.07% -0.022 pp | 0.00% 0.000 pp | USD3.38 +4.4% | 7 qtrs — |
| 50 | XTX TOPCO LTD | 82.9K -8.7K (-9.5%) | 292.5K -73.8K (-20.1%) | 0.06% -0.020 pp | 0.01% -0.011 pp | USD4.00 -11.8% | 2 qtrs — |
| 51 | DAFNA CAPITAL MANAGEMENT LLC | 77.1K -45.0K (-36.9%) | 272.1K -216.2K (-44.3%) | 0.06% -0.051 pp | 0.06% -0.057 pp | USD3.53 +0.0% | 7 qtrs — |
| 52 | DEUTSCHE BANK AG\ | 70.8K -6.8K (-8.7%) | 249.8K -60.3K (-19.4%) | 0.05% -0.016 pp | 0.00% +0.000 pp | USD3.41 +3.5% | 7 qtrs — |
| 53 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 64.5K +— (+0.0%) | 227.8K -30.3K (-11.8%) | 0.05% -0.009 pp | 0.00% -0.001 pp | USD3.11 +13.5% | 3 qtrs — |
| 54 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 56.8K +10.8K (+23.6%) | 200.4K +16.7K (+9.1%) | 0.04% +0.001 pp | 0.00% 0.000 pp | USD3.91 -9.7% | 2 qtrs — |
| 55 | METLIFE INVESTMENT MANAGEMENT, LLC | 49.7K +19.6K (+65.3%) | 175.4K +55.2K (+45.9%) | 0.04% +0.010 pp | 0.00% +0.000 pp | USD3.06 +15.4% | 7 qtrs — |
| 56 | PRICE T ROWE ASSOCIATES INC /MD/ | 46.8K +9.5K (+25.6%) | 166.0K +17.0K (+11.4%) | 0.03% +0.002 pp | 0.00% +0.000 pp | USD2.94 +20.1% | 6 qtrs — |
| 57 | ALLIANCEBERNSTEIN L.P. | 41.9K -7.7K (-15.6%) | 147.7K -50.6K (-25.5%) | 0.03% -0.013 pp | 0.00% +0.000 pp | USD3.12 +13.1% | 7 qtrs — |
| 58 | INVESCO LTD. | 40.2K +1.4K (+3.7%) | 141.9K -13.2K (-8.5%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD2.03 +73.9% | 7 qtrs — |
| 59 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 40.0K +6.0K (+17.6%) | 141.3K +5.1K (+3.8%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD2.98 +18.5% | 6 qtrs — |
| 60 | MAGNETAR FINANCIAL LLC | 39.1K +— (+0.0%) | 138.0K -18.4K (-11.7%) | 0.03% -0.006 pp | 0.00% +0.000 pp | USD34.87 -89.9% | 23 qtrs — |
| 61 | INTECH INVESTMENT MANAGEMENT LLC | 36.9K +759.0 (+2.1%) | 130.4K -14.3K (-9.9%) | 0.03% -0.005 pp | 0.00% 0.000 pp | USD2.04 +73.0% | 6 qtrs — |
| 62 | LPL FINANCIAL LLC | 31.9K -13.2K (-29.3%) | 112.6K -67.8K (-37.6%) | 0.02% -0.016 pp | 0.00% +0.000 pp | USD2.30 +53.5% | 5 qtrs — |
| 63 | DLK INVESTMENT MANAGEMENT, LLC | 25.3K +— (+0.0%) | 89.3K -11.9K (-11.7%) | 0.02% -0.004 pp | 0.03% -0.005 pp | USD1.65 +113.9% | 9 qtrs — |
| 64 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 24.8K +1.6K (+7.0%) | 87.4K -5.1K (-5.6%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD3.44 +2.6% | 7 qtrs — |
| 65 | RUSSELL INVESTMENTS GROUP, LTD. | 24.5K -8.0K (-24.5%) | 86.6K -43.4K (-33.4%) | 0.02% -0.011 pp | 0.00% 0.000 pp | USD2.38 +48.3% | 6 qtrs — |
| 66 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24.4K -15.4K (-38.7%) | 86.1K -73.1K (-45.9%) | 0.02% -0.017 pp | 0.00% +0.000 pp | USD3.48 +1.4% | 8 qtrs — |
| 67 | SG AMERICAS SECURITIES, LLC | 24.4K +24.4K (+100.0%) | 86.0K +86.0K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 68 | CALLAN FAMILY OFFICE, LLC | 23.8K +23.8K (+100.0%) | 84.2K +84.2K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.002 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 69 | SAXONY CAPITAL MANAGEMENT, LLC | 23.8K +— (+0.0%) | 83.9K -11.2K (-11.8%) | 0.02% -0.004 pp | 0.05% -0.011 pp | USD1.86 +89.8% | 9 qtrs — |
| 70 | SEI INVESTMENTS CO | 23.0K +— (+0.0%) | 81.2K -10.8K (-11.8%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD1.99 +77.4% | 5 qtrs — |
| 71 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 22.8K +— (+0.0%) | 80.6K -10.7K (-11.8%) | 0.02% -0.003 pp | 0.00% 0.000 pp | USD1.99 +77.4% | 5 qtrs — |
| 72 | GSA CAPITAL PARTNERS LLP | 20.9K +20.9K (+100.0%) | 74.0K +74.0K (+100.0%) | 0.02% +0.015 pp | 0.01% +0.006 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 73 | HENRICKSON NAUTA WEALTH ADVISORS, INC. | 19.4K +19.4K (+100.0%) | 68.7K +68.7K (+100.0%) | 0.01% +0.014 pp | 0.01% +0.010 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 74 | COMMONWEALTH EQUITY SERVICES, LLC | 17.8K -5.0K (-21.9%) | 62.9K -28.1K (-30.9%) | 0.01% -0.007 pp | 0.00% +0.000 pp | USD3.93 -10.2% | 8 qtrs — |
| 75 | CITIGROUP INC | 16.1K +12.7K (+367.7%) | 56.9K +43.1K (+312.8%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD3.46 +2.0% | 7 qtrs — |
| 76 | AXQ CAPITAL, LP | 16.1K +16.1K (+100.0%) | 56.8K +56.8K (+100.0%) | 0.01% +0.012 pp | 0.01% +0.013 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 77 | IEQ CAPITAL, LLC | 16.1K -4.5K (-22.0%) | 56.7K -25.7K (-31.2%) | 0.01% -0.006 pp | 0.00% 0.000 pp | USD1.45 +143.4% | 4 qtrs — |
| 78 | PROSHARE ADVISORS LLC | 15.7K +3.3K (+27.0%) | 55.5K +6.0K (+12.0%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD2.93 +20.5% | 6 qtrs — |
| 79 | VOYA INVESTMENT MANAGEMENT LLC | 14.4K +805.0 (+5.9%) | 50.7K -3.5K (-6.5%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.65 -3.3% | 7 qtrs — |
| 80 | ETHIC INC. | 12.1K -3.1K (-20.4%) | 42.7K -18.1K (-29.8%) | 0.01% -0.005 pp | 0.00% 0.000 pp | USD2.68 +31.7% | 3 qtrs — |
| 81 | ENGINEERS GATE MANAGER LP | 12.1K +12.1K (+100.0%) | 42.6K +42.6K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.001 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 82 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 11.7K +125.0 (+1.1%) | 41.5K -8.5K (-17.0%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD1.51 +133.8% | 4 qtrs — |
| 83 | QUANTINNO CAPITAL MANAGEMENT LP | 10.8K +10.8K (+100.0%) | 38.2K +38.2K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 84 | HSBC HOLDINGS PLC | 10.5K +— (+0.0%) | 37.7K -3.8K (-9.2%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD4.00 -11.8% | 2 qtrs — |
| 85 | CWM, LLC | 10.4K +331.0 (+3.3%) | 37.0K -3.0K (-7.5%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.49 +136.9% | 4 qtrs — |
| 86 | AVISO WEALTH MANAGEMENT | 10.3K +— (+0.0%) | 36.5K -4.9K (-11.7%) | 0.01% -0.002 pp | 0.02% -0.003 pp | USD4.44 -20.5% | 8 qtrs — |
| 87 | ROYAL BANK OF CANADA | 10.3K +1.5K (+16.5%) | 36.0K +— (+0.0%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.84 -8.1% | 22 qtrs — |
| 88 | ADVISOR GROUP HOLDINGS, INC. | 9.3K +2.8K (+42.5%) | 32.9K +12.8K (+63.9%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD3.76 -6.1% | 23 qtrs — |
| 89 | NEW YORK STATE COMMON RETIREMENT FUND | 9.1K +— (+0.0%) | 32.1K -4.3K (-11.8%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.68 -4.1% | 7 qtrs — |
| 90 | LEGAL & GENERAL GROUP PLC | 8.9K +839.0 (+10.4%) | 31.5K -838.0 (-2.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.58 -1.4% | 7 qtrs — |
| 91 | AMERITAS INVESTMENT PARTNERS, INC. | 6.9K +— (+0.0%) | 24.2K -3.2K (-11.8%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD3.68 -4.1% | 7 qtrs — |
| 92 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 5.3K -689.0 (-11.5%) | 18.7K -5.3K (-21.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.60 -1.9% | 7 qtrs — |
| 93 | TOWER RESEARCH CAPITAL LLC (TRC) | 4.0K -1.6K (-28.8%) | 14.1K -8.3K (-37.1%) | 0.00% -0.002 pp | 0.00% 0.000 pp | USD2.35 +50.2% | 6 qtrs — |
| 94 | JONES FINANCIAL COMPANIES LLLP | 3.0K +— (+0.0%) | 10.6K -360.0 (-3.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.68 +31.7% | 3 qtrs — |
| 95 | AMALGAMATED BANK | 2.7K +288.0 (+11.9%) | 10.0K +— (+0.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.66 -3.6% | 7 qtrs — |
| 96 | SIMPLEX TRADING, LLC | 2.7K -5.5K (-67.0%) | 9.5K -22.5K (-70.4%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD2.81 +25.6% | 14 qtrs — |
| 97 | LOS ANGELES CAPITAL MANAGEMENT LLC | 1.7K +1.7K (+100.0%) | 8.0K +8.0K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD3.53 +0.0% | 1 qtrs NEW |
| 98 | EVERSOURCE WEALTH ADVISORS, LLC | 958.00 +11.0 (+1.2%) | 3.4K -406.0 (-10.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.54 +39.0% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 34 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard U.S. Momentum Factor ETF VFMO | 0.09% | 1.49M | 0.13% |
| 2 | Vanguard Global Momentum Factor ETF VMO.TO | 0.05% | 165.3K | 0.38% |
| 3 | iShares Micro-Cap ETF IWC | 0.03% | 464.9K | 0.60% |
| 4 | Vanguard Russell 2000 Growth ETF VTWG | 0.02% | 322.0K | 0.06% |
| 5 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.02% | 193.5K | 0.40% |
| 6 | iShares Ageing Population UCITS ETF AGED.L | 0.01% | 115.0K | 0.40% |
| 7 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 101.1K | 0.40% |
| 8 | Vanguard Russell 2000 ETF VTWO | 0.01% | 1.74M | 0.06% |
| 9 | iShares Biotechnology ETF IBB | 0.01% | 879.2K | 0.44% |
| 10 | iShares Russell 2000 Value ETF IWN | 0.01% | 917.8K | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
5.50M
Cash buys
—
Cash sales
4.00
Net activity
-5,495,779
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | Redmile Group, LLC | 10% Owner | S-Sale | D | Common Stock | 2,634,506 | 3.28 | 8.64M | 12,666,731 | I | ↗ |
| 2026-04-01 | Redmile Group, LLC | 10% Owner | S-Sale | D | Common Stock | 169,265 | 3.80 | 643.0K | 15,301,237 | I | ↗ |
| 2026-03-31 | Redmile Group, LLC | 10% Owner | S-Sale | D | Common Stock | 196,229 | 3.75 | 736.3K | 15,470,502 | I | ↗ |
| 2026-02-13 | Zaki Mohamed | Officer | A-Award | A | Common Shares | 285,200 | 3.99 | 1.14M | 707,020 | D | ↗ |
| 2026-02-13 | MALLIK AMEET | Director / Officer | F-InKind | D | Common Shares | 103,231 | 3.99 | 411.9K | 1,446,769 | D | ↗ |
| 2026-02-13 | Kallebo Lisa Michelle | Officer | F-InKind | D | Common Shares | 5,433 | 3.99 | 21.7K | 128,224 | D | ↗ |
| 2026-02-13 | GRAHAM PETER J | Officer | F-InKind | D | Common Shares | 33,294 | 3.99 | 132.8K | 620,540 | D | ↗ |
| 2026-02-13 | Carmona Jose | Officer | F-InKind | D | Common Shares | 25,880 | 3.99 | 103.3K | 734,376 | D | ↗ |
| 2025-12-06 | Zaki Mohamed | Officer | F-InKind | D | Common Shares | 41,068 | 3.29 | 135.1K | 421,820 | D | ↗ |
| 2025-12-06 | MALLIK AMEET | Director / Officer | F-InKind | D | Common Shares | 233,146 | 3.29 | 767.1K | 1,319,101 | D | ↗ |
| 2025-12-06 | Kallebo Lisa Michelle | Officer | F-InKind | D | Common Shares | 7,140 | 3.29 | 23.5K | 70,757 | D | ↗ |
| 2025-12-06 | GRAHAM PETER J | Officer | F-InKind | D | Common Shares | 49,508 | 3.29 | 162.9K | 359,034 | D | ↗ |
| 2025-12-06 | Carmona Jose | Officer | F-InKind | D | Common Shares | 53,236 | 3.29 | 175.1K | 488,656 | D | ↗ |
| 2025-10-27 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Pre-Funded Warrants | 3,846,153 | 0.00 | — | 3,846,153 | D | ↗ |
| 2025-06-13 | Squarer Ron | Director | F-InKind | D | Common Shares | 15,184 | 3.58 | 54.4K | 93,627 | D | ↗ |
| 2025-06-13 | Sandor Victor | Director | F-InKind | D | Common Shares | 12,600 | 3.58 | 45.1K | 108,286 | D | ↗ |
| 2025-06-13 | Monges Viviane | Director | F-InKind | D | Common Shares | 2,584 | 3.58 | 9.3K | 144,043 | D | ↗ |
| 2025-06-13 | Hug Peter | Director | F-InKind | D | Common Shares | 2,144 | 3.58 | 7.7K | 220,500 | D | ↗ |
| 2025-06-13 | BIZZARI JEAN-PIERRE | Director | F-InKind | D | Common Shares | 12,600 | 3.58 | 45.1K | 106,902 | D | ↗ |
| 2025-06-13 | Azelby Robert | Director | F-InKind | D | Common Shares | 12,600 | 3.58 | 45.1K | 80,405 | D | ↗ |
| 2025-06-11 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Pre-Funded Warrants | 15,734,267 | 0.00 | — | 15,734,267 | I | ↗ |
| 2025-06-03 | Squarer Ron | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 108,811 | D | ↗ |
| 2025-06-03 | Sandor Victor | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 120,886 | D | ↗ |
| 2025-06-03 | Monges Viviane | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 146,627 | D | ↗ |
| 2025-06-03 | Hug Peter | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 222,644 | D | ↗ |
| 2025-06-03 | COUGHLIN TIMOTHY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-03 | BIZZARI JEAN-PIERRE | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 119,502 | D | ↗ |
| 2025-06-03 | Azelby Robert | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 93,005 | D | ↗ |
| 2025-05-15 | WILD HANS PETER | 10% Owner | J-Other | A | Common Shares | 9,788,944 | 0.00 | — | 9,788,944 | D | ↗ |
| 2025-05-15 | Pfisterer Thomas | Other | J-Other | D | Common Shares | 451,856 | 0.00 | — | 173,899 | D | ↗ |
| 2025-05-06 | MALLIK AMEET | Director / Officer | F-InKind | D | Common Shares | 26,758 | 1.29 | 34.5K | 1,552,247 | D | ↗ |
| 2025-02-13 | Zaki Mohamed | Officer | A-Award | A | Common Shares | 230,000 | 1.61 | 370.3K | 462,888 | D | ↗ |
| 2025-02-13 | MALLIK AMEET | Director / Officer | A-Award | A | Common Shares | 650,000 | 1.61 | 1.05M | 1,579,005 | D | ↗ |
| 2025-02-13 | Kallebo Lisa Michelle | Officer | A-Award | A | Common Shares | 41,900 | 1.61 | 67.5K | 77,897 | D | ↗ |
| 2025-02-13 | GRAHAM PETER J | Officer | A-Award | A | Common Shares | 220,000 | 1.61 | 354.2K | 408,542 | D | ↗ |
| 2025-02-13 | Carmona Jose | Officer | A-Award | A | Common Shares | 240,000 | 1.61 | 386.4K | 541,892 | D | ↗ |
| 2024-12-11 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Common Shares, par value CHF 0.08 per share | 50,000 | 2.28 | 114.0K | 13,095,712 | D | ↗ |
| 2024-12-06 | Zaki Mohamed | Officer | F-InKind | D | Common Shares | 37,112 | 3.13 | 116.2K | 232,888 | D | ↗ |
| 2024-12-06 | MALLIK AMEET | Director / Officer | F-InKind | D | Common Shares | 238,343 | 3.13 | 746.0K | 929,005 | D | ↗ |
| 2024-12-06 | Kallebo Lisa Michelle | Officer | F-InKind | D | Common Shares | 6,503 | 3.13 | 20.4K | 35,997 | D | ↗ |
| 2024-12-06 | GRAHAM PETER J | Officer | F-InKind | D | Common Shares | 41,458 | 3.13 | 129.8K | 188,542 | D | ↗ |
| 2024-12-06 | Carmona Jose | Officer | F-InKind | D | Common Shares | 48,108 | 3.13 | 150.6K | 301,892 | D | ↗ |
| 2024-12-04 | Redmile Group, LLC | 10% Owner | J-Other | A | Pre-Funded Warrants | 26,656 | 0.00 | — | 6,133,837 | D | ↗ |
| 2024-07-01 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Common Shares, par value CHF 0.08 per share | 400,000 | 2.81 | 1.12M | 15,669,217 | — | ↗ |
| 2024-06-17 | Squarer Ron | Director | S-Sale | D | Common Shares | 6,995 | 2.89 | 20.2K | 80,663 | — | ↗ |
| 2024-06-17 | Sandor Victor | Director | S-Sale | D | Common Shares | 6,995 | 2.89 | 20.2K | 80,886 | — | ↗ |
| 2024-06-17 | Pfisterer Thomas | Director | S-Sale | D | Common Shares | 1,437 | 2.89 | 4.2K | 213,900 | — | ↗ |
| 2024-06-17 | Monges Viviane | Director | S-Sale | D | Common Shares | 1,437 | 2.89 | 4.2K | 106,627 | — | ↗ |
| 2024-06-17 | Hug Peter | Director | S-Sale | D | Common Shares | 1,193 | 2.89 | 3.4K | 182,644 | — | ↗ |
| 2024-06-17 | BIZZARI JEAN-PIERRE | Director | S-Sale | D | Common Shares | 6,995 | 2.89 | 20.2K | 79,502 | — | ↗ |
| 2024-06-17 | Azelby Robert | Director | S-Sale | D | Common Shares | 6,995 | 2.89 | 20.2K | 53,005 | — | ↗ |
| 2024-06-13 | Squarer Ron | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 87,658 | — | ↗ |
| 2024-06-13 | Sandor Victor | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 87,881 | — | ↗ |
| 2024-06-13 | Pfisterer Thomas | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 215,337 | — | ↗ |
| 2024-06-13 | Monges Viviane | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 108,064 | — | ↗ |
| 2024-06-13 | Hug Peter | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 183,837 | — | ↗ |
| 2024-06-13 | BIZZARI JEAN-PIERRE | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 86,497 | — | ↗ |
| 2024-06-13 | Azelby Robert | Director | A-Award | A | Common Shares | 40,000 | 0.00 | — | 60,000 | — | ↗ |
| 2024-05-08 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Pre-Funded Warrants | 8,163,265 | 0.00 | — | 8,163,265 | — | ↗ |
| 2024-05-07 | MALLIK AMEET | Director / Officer | S-Sale | D | Common Shares | 29,731 | 4.48 | 133.2K | 1,167,348 | — | ↗ |
| 2024-02-07 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 107,590 | 3.99 | 429.4K | 107,590 | — | ↗ |
| 2024-02-02 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 144,517 | 3.59 | 518.4K | 144,517 | — | ↗ |
| 2024-02-01 | Redmile Group, LLC | 10% Owner | J-Other | D | Cash-settled Swaps | 19,700 | 3.25 | 64.0K | 1,180,136 | — | ↗ |
| 2024-01-31 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 150,000 | 3.26 | 489.1K | 150,000 | — | ↗ |
| 2024-01-30 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 3.14 | 314.5K | 100,000 | — | ↗ |
| 2024-01-29 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 150,000 | 3.08 | 462.4K | 150,000 | — | ↗ |
| 2024-01-26 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 2.66 | 265.7K | 100,000 | — | ↗ |
| 2024-01-25 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 2.49 | 248.8K | 100,000 | — | ↗ |
| 2024-01-24 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 50,000 | 2.11 | 105.7K | 50,000 | — | ↗ |
| 2024-01-16 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 53,900 | 1.91 | 103.0K | 53,900 | — | ↗ |
| 2024-01-12 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 93,424 | 2.14 | 199.9K | 93,424 | — | ↗ |
| 2024-01-11 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 2.10 | 210.1K | 100,000 | — | ↗ |
| 2024-01-10 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 2.17 | 216.8K | 100,000 | — | ↗ |
| 2024-01-09 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 2.06 | 206.1K | 100,000 | — | ↗ |
| 2024-01-08 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 100,000 | 1.93 | 193.3K | 100,000 | — | ↗ |
| 2024-01-05 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 50,000 | 1.96 | 98.0K | 50,000 | — | ↗ |
| 2024-01-04 | Redmile Group, LLC | 10% Owner | P-Purchase | A | Cash-settled Swaps | 28,652 | 1.68 | 48.0K | 28,652 | — | ↗ |
| 2024-01-03 | Redmile Group, LLC | 10% Owner | J-Other | D | Cash-settled Swaps | 59,986 | 3.25 | 195.0K | 1,199,836 | — | ↗ |
| 2024-01-02 | Zaki Mohamed | Officer | — | D | Common Shares | 0 | 0.00 | — | 270,000 | — | ↗ |
| 2024-01-02 | WILD HANS PETER | 10% Owner | — | D | Common shares | 0 | 0.00 | — | 9,788,944 | — | ↗ |
| 2024-01-02 | Squarer Ron | Director | — | D | Stock Options (Right to Buy) | 497,542 | 18.75 | 9.33M | 0 | — | ↗ |
| 2024-01-02 | Sandor Victor | Director | — | D | Common Shares | 0 | 0.00 | — | 47,881 | — | ↗ |
| 2024-01-02 | Rivers Tyrell | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-02 | Redmile Group, LLC | 10% Owner | — | I | Cash-settled Swaps | 15,000 | 4.38 | 65.7K | 0 | — | ↗ |
| 2024-01-02 | Pfisterer Thomas | Director | — | D | Common shares | 0 | 0.00 | — | 607,193 | — | ↗ |
| 2024-01-02 | Monges Viviane | Director | — | D | Stock Options (Right to Buy) | 21,190 | 27.53 | 583.4K | 0 | — | ↗ |
| 2024-01-02 | MALLIK AMEET | Director / Officer | — | D | Common Shares | 0 | 0.00 | — | 1,197,079 | — | ↗ |
| 2024-01-02 | Kallebo Lisa Michelle | Officer | — | D | Common Shares | 0 | 0.00 | — | 42,500 | — | ↗ |
| 2024-01-02 | Hug Peter | Director | — | D | Common Shares | 0 | 0.00 | — | 143,837 | — | ↗ |
| 2024-01-02 | GRAHAM PETER J | Officer | — | D | Stock Options (Right to Buy) | 460,000 | 4.42 | 2.03M | 0 | — | ↗ |
| 2024-01-02 | Carmona Jose | Officer | — | D | Stock Options (Right to Buy) | 460,000 | 3.04 | 1.40M | 0 | — | ↗ |
| 2024-01-02 | BIZZARI JEAN-PIERRE | Director | — | D | Stock Options (Right to Buy) | 30,937 | 8.54 | 264.2K | 0 | — | ↗ |
| 2024-01-02 | Azelby Robert | Director | — | D | Common Shares | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2010-12-08 | SWITZ ROBERT E | Director / Officer | D-Return | D | Stock Option (right to Buy) | 89,964 | 15.82 | 1.42M | 0 | — | ↗ |
| 2010-12-08 | SPIVEY WILLIAM | Director | D-Return | D | Restricted Stock Units (2-10) | 10,687 | 0.00 | — | 0 | — | ↗ |
| 2010-12-08 | Rehfeld John E | Director | D-Return | D | Director Option (Right to Buy) | 4,112 | 16.29 | 67.0K | 0 | — | ↗ |
| 2010-12-08 | ROBERTS DAVID A | Director | D-Return | D | Restricted Stock Units (2-10) | 10,687 | 0.00 | — | 0 | — | ↗ |
| 2010-12-08 | MARTIN LOIS M | Director | D-Return | D | Director Option (Right to Buy) | 2,770 | 24.18 | 67.0K | 0 | — | ↗ |
| 2010-12-08 | FORET MICKEY P | Director | D-Return | D | Director Option (Right to Buy) | 4,100 | 16.17 | 66.3K | 0 | — | ↗ |
| 2010-02-10 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Units (2-10) | 10,687 | 6.55 | 70.0K | 10,687 | — | ↗ |
| 2010-02-10 | Rehfeld John E | Director | A-Award | A | Restricted Stock Units (2-10) | 10,687 | 6.55 | 70.0K | 10,687 | — | ↗ |
| 2010-02-10 | ROBERTS DAVID A | Director | A-Award | A | Restricted Stock Units (2-10) | 10,687 | 6.55 | 70.0K | 10,687 | — | ↗ |
| 2010-02-10 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Units (2-10) | 10,687 | 6.55 | 70.0K | 10,687 | — | ↗ |
| 2010-02-10 | FORET MICKEY P | Director | A-Award | A | Restricted Stock Units (2-10) | 10,687 | 6.55 | 70.0K | 10,687 | — | ↗ |
| 2010-01-09 | SWITZ ROBERT E | Officer | F-InKind | D | Common Stock | 23,873 | 6.73 | 160.7K | 373,119 | — | ↗ |
| 2009-12-18 | SWITZ ROBERT E | Officer | M-Exempt | A | Common Stock | 225,000 | 6.05 | 1.36M | 412,333 | — | ↗ |
| 2009-11-23 | SWITZ ROBERT E | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 192,977 | 6.00 | 1.16M | 192,977 | — | ↗ |
| 2009-09-30 | SWITZ ROBERT E | Officer | A-Award | A | Restricted Stock Unit (9-09) P | 209,832 | 0.00 | — | 209,832 | — | ↗ |
| 2009-09-08 | SWITZ ROBERT E | Officer | I-Discretionary | D | Common Stock | 2,908 | 8.11 | 23.6K | 0 | — | ↗ |
| 2009-03-06 | FORET MICKEY P | Director | P-Purchase | A | Common Stock | 10,000 | 2.75 | 27.5K | 20,000 | — | ↗ |
| 2009-03-05 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Unit (3-09) | 24,137 | 0.00 | — | 24,137 | — | ↗ |
| 2009-03-05 | Rehfeld John E | Director | A-Award | A | Restricted Stock Unit (3-09) | 24,137 | 0.00 | — | 24,137 | — | ↗ |
| 2009-03-05 | ROBERTS DAVID A | Director | A-Award | A | Restricted Stock Unit (3-09) | 24,137 | 0.00 | — | 24,137 | — | ↗ |
| 2009-03-05 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Unit (3-09) | 24,137 | 0.00 | — | 24,137 | — | ↗ |
| 2009-03-05 | FORET MICKEY P | Director | A-Award | A | Restricted Stock Unit (3-09) | 24,137 | 0.00 | — | 24,137 | — | ↗ |
| 2009-01-09 | SWITZ ROBERT E | Officer | M-Exempt | A | Common Stock | 62,500 | 0.00 | — | 208,623 | — | ↗ |
| 2008-12-23 | SWITZ ROBERT E | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 405,379 | 4.85 | 1.97M | 405,379 | — | ↗ |
| 2008-12-22 | FORET MICKEY P | Director | P-Purchase | A | Convertible Notes due 2013 | 213 | 28.09 | 6.0K | 1,779 | — | ↗ |
| 2008-12-19 | FORET MICKEY P | Director | P-Purchase | A | Convertible Notes due 2013 | 1,566 | 28.09 | 44.0K | 1,566 | — | ↗ |
| 2008-12-16 | SWITZ ROBERT E | Officer | A-Award | A | Common Stock | 35 | 0.00 | — | 2,971 | — | ↗ |
| 2008-11-01 | ROBERTS DAVID A | Director | A-Award | A | Restricted Stock Unit (11-08) | 3,720 | 0.00 | — | 3,720 | — | ↗ |
| 2008-03-07 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-03-07 | Rehfeld John E | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-03-07 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-03-07 | GILLIGAN J KEVIN | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-03-07 | FORET MICKEY P | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-03-07 | BLANCHARD JOHN A III | Director | A-Award | A | Restricted Stock Unit (3-08) | 5,072 | 0.00 | — | 5,072 | — | ↗ |
| 2008-01-09 | SWITZ ROBERT E | Officer | I-Discretionary | A | Common Stock | 2,936 | 13.11 | 38.5K | 2,936 | — | ↗ |
| 2008-01-04 | SWITZ ROBERT E | Officer | A-Award | A | 401(k) Excess Plan Phantom Stock Units | 8,339 | 0.00 | — | 8,339 | — | ↗ |
| 2007-12-17 | SWITZ ROBERT E | Officer | A-Award | A | Restricted Stock Unit (12-07) P | 70,000 | 0.00 | — | 70,000 | — | ↗ |
| 2007-12-16 | SWITZ ROBERT E | Officer | M-Exempt | D | Restricted Stock Unit (12-04) | 12,500 | 0.00 | — | 12,500 | — | ↗ |
| 2007-06-21 | SWITZ ROBERT E | Officer | I-Discretionary | D | Phantom Stock Unit | 9,415 | 0.00 | — | 0 | — | ↗ |
| 2007-06-20 | SWITZ ROBERT E | Officer | S-Sale | D | Common Stock | 8,000 | 19.02 | 152.2K | 129,297 | — | ↗ |
| 2007-03-07 | SPIVEY WILLIAM | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,112 | 16.29 | 67.0K | 4,112 | — | ↗ |
| 2007-03-07 | Rehfeld John E | Director | A-Award | A | Restricted Stock Unit (3-07) | 1,534 | 0.00 | — | 1,534 | — | ↗ |
| 2007-03-07 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Unit (3-07) | 1,534 | 0.00 | — | 1,534 | — | ↗ |
| 2007-03-07 | GILLIGAN J KEVIN | Director | A-Award | A | Restricted Stock Unit (3-07) | 1,534 | 0.00 | — | 1,534 | — | ↗ |
| 2007-03-07 | FORET MICKEY P | Director | A-Award | A | Restricted Stock Unit (3-07) | 1,534 | 0.00 | — | 1,534 | — | ↗ |
| 2007-03-07 | BLANCHARD JOHN A III | Director | A-Award | A | Restricted Stock Unit (3-07) | 1,534 | 0.00 | — | 1,534 | — | ↗ |
| 2007-03-03 | HEMMADY GOKUL V | Officer | M-Exempt | A | Common Stock | 1,667 | 0.00 | — | 20,201 | — | ↗ |
| 2006-12-18 | SWITZ ROBERT E | Officer | A-Award | A | Incentive Stock Option (right to buy) | 6,854 | 14.59 | 100.0K | 6,854 | — | ↗ |
| 2006-12-18 | HEMMADY GOKUL V | Officer | A-Award | A | Incentive Stock Option (right to buy) | 6,854 | 14.59 | 100.0K | 6,854 | — | ↗ |
| 2006-12-16 | SWITZ ROBERT E | Officer | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 141,384 | — | ↗ |
| 2006-12-16 | HEMMADY GOKUL V | Officer | M-Exempt | A | Common Stock | 2,293 | 0.00 | — | 20,212 | — | ↗ |
| 2006-08-13 | SWITZ ROBERT E | Officer | F-InKind | D | Common Stock | 10,121 | 14.23 | 144.0K | 128,884 | — | ↗ |
| 2006-06-20 | Rehfeld John E | Director | P-Purchase | A | Common Stock | 500 | 16.14 | 8.1K | 1,000 | — | ↗ |
| 2006-06-07 | SWITZ ROBERT E | Officer | I-Discretionary | A | Phantom Stock Unit | 5,838 | 0.00 | — | 9,416 | — | ↗ |
| 2006-06-07 | MARTIN LOIS M | Director | P-Purchase | A | Common Stock | 1,000 | 17.46 | 17.5K | 1,000 | — | ↗ |
| 2006-06-07 | FORET MICKEY P | Director | P-Purchase | A | Common Stock | 10,000 | 17.46 | 174.6K | 10,000 | — | ↗ |
| 2006-06-05 | BLANCHARD JOHN A III | Director | P-Purchase | A | Common Stock | 9,400 | 17.72 | 166.6K | 39,226 | — | ↗ |
| 2006-03-08 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Unit (3-06) | 1,032 | 0.00 | — | 1,032 | — | ↗ |
| 2006-03-08 | Rehfeld John E | Director | A-Award | A | Restricted Stock Unit (3-06) | 1,032 | 0.00 | — | 1,032 | — | ↗ |
| 2006-03-08 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Unit (3-06) | 1,032 | 0.00 | — | 1,032 | — | ↗ |
| 2006-03-08 | GILLIGAN J KEVIN | Director | A-Award | A | Restricted Stock Unit (3-06) | 1,032 | 0.00 | — | 1,032 | — | ↗ |
| 2006-03-08 | FORET MICKEY P | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,770 | 24.18 | 67.0K | 2,770 | — | ↗ |
| 2006-03-08 | BLANCHARD JOHN A III | Director | A-Award | A | Restricted Stock Unit (3-06) | 1,032 | 0.00 | — | 1,032 | — | ↗ |
| 2006-03-03 | HEMMADY GOKUL V | Officer | M-Exempt | D | Phantom Stock Unit | 1,666 | 0.00 | — | 3,334 | — | ↗ |
| 2005-12-16 | SWITZ ROBERT E | Officer | M-Exempt | D | Restricted Stock Unit (12-04) | 12,500 | 0.00 | — | 37,500 | — | ↗ |
| 2005-12-16 | HEMMADY GOKUL V | Officer | M-Exempt | D | Restricted Stock Unit (12-04) | 2,292 | 0.00 | — | 6,879 | — | ↗ |
| 2005-12-15 | SWITZ ROBERT E | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 120,818 | 23.91 | 2.89M | 120,818 | — | ↗ |
| 2005-12-15 | HEMMADY GOKUL V | Officer | A-Award | A | Incentive Stock Option (right to buy) | 4,182 | 23.91 | 100.0K | 4,182 | — | ↗ |
| 2005-11-01 | SWITZ ROBERT E | Officer | F-InKind | D | Common Stock | 4,671 | 17.49 | 81.7K | 131,800 | — | ↗ |
| 2005-11-01 | HEMMADY GOKUL V | Officer | F-InKind | D | Common Stock | 1,167 | 17.49 | 20.4K | 15,319 | — | ↗ |
| 2005-08-13 | SWITZ ROBERT E | Director / Officer | F-InKind | D | Common Stock | 10,121 | 23.91 | 242.0K | 136,471 | — | ↗ |
| 2005-03-03 | HEMMADY GOKUL V | Officer | M-Exempt | A | Common Stock | 11,666 | 0.00 | — | 118,392 | — | ↗ |
| 2005-03-02 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-03-02 | Rehfeld John E | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-03-02 | MARTIN LOIS M | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-03-02 | JOHNSON B KRISTINE | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-03-02 | GILLIGAN J KEVIN | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 28,700 | 2.31 | 66.3K | 28,700 | — | ↗ |
| 2005-03-02 | FORET MICKEY P | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-03-02 | BLANCHARD JOHN A III | Director | A-Award | A | Restricted Stock Unit (3-05) | 10,869 | 0.00 | — | 10,869 | — | ↗ |
| 2005-01-03 | SPIVEY WILLIAM | Director | A-Award | A | Restricted Stock Unit (1-05) | 9,328 | 0.00 | — | 9,328 | — | ↗ |
| 2004-12-16 | SWITZ ROBERT E | Director / Officer | A-Award | A | Restricted Stock Unit (12-04) | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2004-12-16 | HEMMADY GOKUL V | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 192,700 | 2.68 | 516.4K | 192,700 | — | ↗ |
| 2004-11-01 | SWITZ ROBERT E | Director / Officer | F-InKind | D | Common Stock | 54,500 | 2.15 | 117.2K | 1,026,150 | — | ↗ |
| 2004-11-01 | HEMMADY GOKUL V | Officer | F-InKind | D | Common Stock | 14,306 | 2.15 | 30.8K | 106,726 | — | ↗ |
| 2004-09-02 | SPIVEY WILLIAM | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 40,000 | 2.06 | 82.4K | 40,000 | — | ↗ |
| 2004-09-02 | Rehfeld John E | Director | A-Award | A | Phantom Stock Unit | 4,045 | 0.00 | — | 4,045 | — | ↗ |
| 2004-09-02 | GILLIGAN J KEVIN | Director | A-Award | A | Phantom Stock Unit | 4,045 | 0.00 | — | 4,045 | — | ↗ |
| 2004-09-01 | SPIVEY WILLIAM | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-09-01 | Rehfeld John E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-09-01 | GILLIGAN J KEVIN | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-08-13 | SWITZ ROBERT E | Director / Officer | F-InKind | D | Common Stock | 70,850 | 2.07 | 146.7K | 1,080,650 | — | ↗ |
| 2004-03-03 | QUIRAM JEFFREY A | Officer | A-Award | A | Phantom Stock Unit | 17,500 | 0.00 | — | 17,500 | — | ↗ |
| 2004-03-03 | MARTIN LOIS M | Director | A-Award | A | Phantom Stock Unit | 8,561 | 0.00 | — | 8,561 | — | ↗ |
| 2004-03-03 | JOHNSON B KRISTINE | Director | A-Award | A | Phantom Stock Unit | 8,561 | 0.00 | — | 8,561 | — | ↗ |
| 2004-03-03 | HEMMADY GOKUL V | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 37,262 | 2.92 | 108.8K | 37,262 | — | ↗ |
| 2004-03-03 | FORET MICKEY P | Director | A-Award | A | Phantom Stock Unit | 8,561 | 0.00 | — | 8,561 | — | ↗ |
| 2004-03-03 | BLANCHARD JOHN A III | Director | A-Award | A | Restricted Stock Unit (3-04) | 8,561 | 0.00 | — | 8,561 | — | ↗ |
| 2004-03-02 | MARTIN LOIS M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2004-01-16 | JOHNSON B KRISTINE | Director | S-Sale | D | Common Stock | 16,000 | 3.67 | 58.7K | 16,000 | — | ↗ |
| 2003-12-29 | QUIRAM JEFFREY A | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 13,320 | 2.83 | 37.7K | 154,518 | — | ↗ |
| 2003-12-29 | HEMMADY GOKUL V | Officer | A-Award | A | Non-Qualified Stock Option (right to buy) | 45,828 | 2.83 | 129.7K | 45,828 | — | ↗ |
| 2003-11-01 | SWITZ ROBERT E | Officer | F-InKind | D | Common Stock | 54,500 | 2.57 | 140.1K | 1,151,500 | — | ↗ |
| 2003-11-01 | QUIRAM JEFFREY A | Officer | F-InKind | D | Common Stock | 17,847 | 2.57 | 45.9K | 145,903 | — | ↗ |
| 2003-11-01 | HEMMADY GOKUL V | Officer | F-InKind | D | Common Stock | 14,306 | 2.57 | 36.8K | 121,032 | — | ↗ |
| 2003-10-06 | HILBERT JAY T | Officer | D-Return | D | Common Stock | 150,000 | 0.00 | — | 0 | — | ↗ |
| 2003-08-29 | SWITZ ROBERT E | Director / Officer | A-Award | A | Common Stock | 650,000 | 0.00 | — | 1,206,000 | — | ↗ |
| 2003-06-28 | QUIRAM JEFFREY A | Officer | D-Return | D | Non-Qualified Stock Option (right to buy) | 69,484 | 11.97 | 831.7K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-412.1K
Shares Outstanding
127.19M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Ameet Mallik Chief Executive Officer | 776.1K | — | 1.05M | — | 582.1K | 48.5K | 2.45M | 42.66% | ↗ |
| 2 | 2025 | Mohamed Zaki Chief Medical Officer | 690.1K | — | 370.3K | — | 431.3K | 23.8K | 1.52M | 24.43% | ↗ |
| 3 | 2025 | Jose “Pepe” Carmona Chief Financial Officer | 525.2K | — | 386.4K | — | 328.3K | 7.1K | 1.25M | 30.99% | ↗ |
| 4 | 2024 | Ameet Mallik Chief Executive Officer | 746.2K | 621.7K | — | — | 425.4K | 44.3K | 1.84M | 0.00% | ↗ |
| 5 | 2024 | Mohamed Zaki Chief Medical Officer | 670.0K | — | — | — | 318.3K | 21.2K | 1.01M | 0.00% | ↗ |
| 6 | 2024 | Jose “Pepe” Carmona Chief Financial Officer | 505.0K | 180.0K | — | — | 239.9K | 8.7K | 933.6K | 0.00% | ↗ |
| 7 | 2023 | Mohamed Zaki Chief Medical Officer | 647.3K | 1.48M | 288.9K | 1.70M | 276.3K | 15.4K | 4.40M | 45.19% | ↗ |
| 8 | 2023 | Ameet Mallik Chief Executive Officer | 721.0K | 705.1K | 1.06M | 881.3K | 367.7K | 45.1K | 3.78M | 51.35% | ↗ |
| 9 | 2023 | Jose “Pepe” Carmona Chief Financial Officer | 480.0K | 180.0K | 374.5K | — | 204.0K | 20.9K | 1.26M | 29.74% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ameet Mallik | Chief Executive Officer & Director | 1M | — |
| Mohamed Zaki | Chief Medical Officer | 1M | — |
| Jose I. Carmona | Chief Financial Officer | 860.6K | male |
| Kristen Harrington-Smith | Chief Commercial Officer | — | female |
| Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer | — | female |
| Marcy Graham | Investor Relations Officer | — | female |
| Nicole Riley | Head of Investor Relations & Corporate Communications | — | female |
| Patrick van Berkel | Chief Scientific Officer | — | — |
| Peter J. Graham | Secretary and Chief Legal & Compliance Officer | — | male |
| David S. Ege | Chief Technical Officer | — | — |
| Kimberly Pope | Senior Vice President & Chief People Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ADCT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
